PATIROMER SORBITEX CALCIUM - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for patiromer sorbitex calcium and what is the scope of patent protection?
Patiromer sorbitex calcium
is the generic ingredient in one branded drug marketed by Vifor Pharma and is included in one NDA. There are thirteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.Patiromer sorbitex calcium has one hundred and ninety-eight patent family members in twenty-seven countries.
One supplier is listed for this compound.
Summary for PATIROMER SORBITEX CALCIUM
International Patents: | 198 |
US Patents: | 13 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for PATIROMER SORBITEX CALCIUM |
DailyMed Link: | PATIROMER SORBITEX CALCIUM at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for PATIROMER SORBITEX CALCIUM
Generic Entry Date for PATIROMER SORBITEX CALCIUM*:
Constraining patent/regulatory exclusivity:
Dosage:
POWDER;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for PATIROMER SORBITEX CALCIUM
Drug Class | Potassium Binder |
Mechanism of Action | Potassium Ion Binding Activity |
Paragraph IV (Patent) Challenges for PATIROMER SORBITEX CALCIUM
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
VELTASSA | for Oral Suspension | patiromer sorbitex calcium | 8.4 g, 16.8 g and 25.2 g | 205739 | 2 | 2019-10-21 |
US Patents and Regulatory Information for PATIROMER SORBITEX CALCIUM
Expired US Patents for PATIROMER SORBITEX CALCIUM
International Patents for PATIROMER SORBITEX CALCIUM
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
South Korea | 101199608 | ⤷ Try a Trial | |
Poland | 3219312 | ⤷ Try a Trial | |
Canada | 2806465 | POLYMERES DE LIAISON IONIQUE ET LEURS UTILISATIONS (ION BINDING POLYMERS AND USES THEREOF) | ⤷ Try a Trial |
Germany | 112005000730 | Ionen bindende Polymere und ihre Verwendung | ⤷ Try a Trial |
Japan | 2012500806 | ⤷ Try a Trial | |
Japan | 2020176155 | 高血圧症及び高カリウム血症を治療するためのカリウム結合剤 (POTASSIUM BINDER FOR TREATING HYPERTENSION AND HYPERKALEMIA) | ⤷ Try a Trial |
Lithuania | PA2018016 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for PATIROMER SORBITEX CALCIUM
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2957286 | CR 2018 00043 | Denmark | ⤷ Try a Trial | PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REG. NO/DATE: EU/1/17/1179/001-009 20170721 |
2957286 | C20190015 00286 | Estonia | ⤷ Try a Trial | PRODUCT NAME: KALTSIUMPATIROMEER;REG NO/DATE: EU/1/17/1179 21.07.2017 |
2365988 | 122018000012 | Germany | ⤷ Try a Trial | PRODUCT NAME: PATIROMER SORBITEX CALCIUM UND SALZE DAVON IN ALLEN VOM GRUNDPATENT GESCHUETZTEN FORMEN; REGISTRATION NO/DATE: EU/1/17/1179 20170719 |
2957286 | LUC00094 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: PATIROMER SORBITEX CALCIUM; AUTHORISATION NUMBER AND DATE: EU/1/17/1179 20170721 |
2957286 | 6/2019 | Austria | ⤷ Try a Trial | PRODUCT NAME: PATIROMER UND SEINE CALCIUM-SALZE; REGISTRATION NO/DATE: EU/1/17/1179 (MITTEILUNG) 20170721 |
1732523 | 300925 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: PATIROMER EN ALLE ZOUTEN DAARVAN; REGISTRATION NO/DATE: EU/1/17/1179/001-009 20170721 |
2957286 | 404 50019-2018 | Slovakia | ⤷ Try a Trial | PRODUCT NAME: PATIROMER SORBITEX KALCIUM; REGISTRATION NO/DATE: EU/1/17/1179/001 - EU/1/17/1179/009 20170721 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.